These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 17613964)

  • 1. Citalopram combined with behavioral therapy reduces cocaine use: a double-blind, placebo-controlled trial.
    Moeller FG; Schmitz JM; Steinberg JL; Green CM; Reist C; Lai LY; Swann AC; Grabowski J
    Am J Drug Alcohol Abuse; 2007; 33(3):367-78. PubMed ID: 17613964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-dose citalopram for cocaine dependence in veteran population-a pilot project.
    Vayalapalli S; Vaughn M; Salles-Shahid K; Byrd-Sellers J; Drexler K
    Am J Addict; 2011; 20(5):485-6. PubMed ID: 21838852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poorer Drinking Outcomes with Citalopram Treatment for Alcohol Dependence: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Charney DA; Heath LM; Zikos E; Palacios-Boix J; Gill KJ
    Alcohol Clin Exp Res; 2015 Sep; 39(9):1756-65. PubMed ID: 26208048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical efficacy of citalopram alone or augmented with bupropion in methadone-stabilized patients.
    Poling J; Pruzinsky R; Kosten TR; Gonsai K; Sofuoglu M; Gonzalez G; Oliveto A
    Am J Addict; 2007; 16(3):187-94. PubMed ID: 17612822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Placebo-controlled comparison of the selective serotonin reuptake inhibitors citalopram and sertraline.
    Stahl SM
    Biol Psychiatry; 2000 Nov; 48(9):894-901. PubMed ID: 11074227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor.
    Lenox-Smith AJ; Jiang Q
    Int Clin Psychopharmacol; 2008 May; 23(3):113-9. PubMed ID: 18408525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Efficacy and tolerability of escitalopram in anxiety disorders: a review].
    Pelissolo A
    Encephale; 2008 Sep; 34(4):400-8. PubMed ID: 18922243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response acceleration with mirtazapine augmentation of citalopram in obsessive-compulsive disorder patients without comorbid depression: a pilot study.
    Pallanti S; Quercioli L; Bruscoli M
    J Clin Psychiatry; 2004 Oct; 65(10):1394-9. PubMed ID: 15491244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combining motivational interviewing with compliance enhancement therapy (MI-CET): development and preliminary evaluation of a new, manual-guided psychosocial adjunct to alcohol-dependence pharmacotherapy.
    Heffner JL; Tran GQ; Johnson CS; Barrett SW; Blom TJ; Thompson RD; Anthenelli RM
    J Stud Alcohol Drugs; 2010 Jan; 71(1):61-70. PubMed ID: 20105415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patients with severe depression may benefit from buspirone augmentation of selective serotonin reuptake inhibitors: results from a placebo-controlled, randomized, double-blind, placebo wash-in study.
    Appelberg BG; Syvälahti EK; Koskinen TE; Mehtonen OP; Muhonen TT; Naukkarinen HH
    J Clin Psychiatry; 2001 Jun; 62(6):448-52. PubMed ID: 11465522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy of citalopram in the treatment of premature ejaculation: a double-blind placebo-controlled, fixed dose, randomized study.
    Safarinejad MR; Hosseini SY
    Int J Impot Res; 2006; 18(2):164-9. PubMed ID: 16107866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An assessment of selective serotonin reuptake inhibitor discontinuation symptoms with citalopram.
    Markowitz JS; DeVane CL; Liston HL; Montgomery SA
    Int Clin Psychopharmacol; 2000 Nov; 15(6):329-33. PubMed ID: 11110008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A placebo-controlled screening trial of olanzapine, valproate, and coenzyme Q10/L-carnitine for the treatment of cocaine dependence.
    Reid MS; Casadonte P; Baker S; Sanfilipo M; Braunstein D; Hitzemann R; Montgomery A; Majewska D; Robinson J; Rotrosen J
    Addiction; 2005 Mar; 100 Suppl 1():43-57. PubMed ID: 15730349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and tolerability of citalopram in the treatment of late-life anxiety disorders: results from an 8-week randomized, placebo-controlled trial.
    Lenze EJ; Mulsant BH; Shear MK; Dew MA; Miller MD; Pollock BG; Houck P; Tracey B; Reynolds CF
    Am J Psychiatry; 2005 Jan; 162(1):146-50. PubMed ID: 15625213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serotonergic Regulation and Cognition after Stroke: The Role of Antidepressant Treatment and Genetic Variation.
    Damsbo AG; Kraglund KL; Buttenschøn HN; Johnsen SP; Andersen G; Mortensen JK
    Cerebrovasc Dis; 2019; 47(1-2):72-79. PubMed ID: 30844812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of contingency management for cocaine dependence treatment: a review of the evidence.
    Schierenberg A; van Amsterdam J; van den Brink W; Goudriaan AE
    Curr Drug Abuse Rev; 2012 Dec; 5(4):320-31. PubMed ID: 23244344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Citalopram plus low-dose pipamperone versus citalopram plus placebo in patients with major depressive disorder: an 8-week, double-blind, randomized study on magnitude and timing of clinical response.
    Wade AG; Crawford GM; Nemeroff CB; Schatzberg AF; Schlaepfer T; McConnachie A; Haazen L; Buntinx E
    Psychol Med; 2011 Oct; 41(10):2089-97. PubMed ID: 21349239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Escitalopram treatment of kleptomania: an open-label trial followed by double-blind discontinuation.
    Koran LM; Aboujaoude EN; Gamel NN
    J Clin Psychiatry; 2007 Mar; 68(3):422-7. PubMed ID: 17388713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Escitalopram in the treatment of panic disorder: a randomized, double-blind, placebo-controlled trial.
    Stahl SM; Gergel I; Li D
    J Clin Psychiatry; 2003 Nov; 64(11):1322-7. PubMed ID: 14658946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methadone versus buprenorphine with contingency management or performance feedback for cocaine and opioid dependence.
    Schottenfeld RS; Chawarski MC; Pakes JR; Pantalon MV; Carroll KM; Kosten TR
    Am J Psychiatry; 2005 Feb; 162(2):340-9. PubMed ID: 15677600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.